| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,588,676 |
|
|
|
Indirect Value
|
$4,891,842 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,480,518 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
AS |
$280.00 |
$43,960 |
D/D |
(157) |
59,633 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-07-21 |
4 |
AS |
$280.00 |
$43,960 |
D/D |
(157) |
54,779 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-08-31 |
4 |
B |
$2.14 |
$48,227 |
D/D |
22,188 |
23,188 |
2.39 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-05-21 |
4 |
OE |
$4.57 |
$68,550 |
D/D |
15,000 |
1,248,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
President & CEO |
• • – |
2008-10-30 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
1,174,415 |
2.81 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-02-11 |
4 |
AS |
$20.14 |
$80,560 |
D/D |
(4,000) |
1,034,031 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-22 |
4 |
AS |
$10.05 |
$100,737 |
D/D |
(10,028) |
130,711 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-22 |
4 |
AS |
$25.05 |
$105,210 |
D/D |
(4,200) |
853,031 |
0 |
% |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-16 |
4 |
AS |
$10.24 |
$111,386 |
D/D |
(10,878) |
157,611 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-17 |
4 |
AS |
$256.16 |
$124,750 |
D/D |
(487) |
59,848 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-03-14 |
4 |
AS |
$25.00 |
$125,000 |
D/D |
(5,000) |
1,318,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-04-03 |
4 |
AS |
$25.03 |
$125,150 |
D/D |
(5,000) |
1,273,031 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
AS |
$258.83 |
$126,050 |
D/D |
(487) |
60,434 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-03-01 |
4 |
AS |
$261.37 |
$127,287 |
D/D |
(487) |
60,921 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-08 |
4 |
AS |
$18.35 |
$129,643 |
D/D |
(7,065) |
938,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-29 |
4 |
AS |
$20.00 |
$130,000 |
D/D |
(6,500) |
1,505,481 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-05-02 |
4 |
AS |
$274.74 |
$133,798 |
D/D |
(487) |
59,790 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2014-09-17 |
4 |
A |
$58.89 |
$138,568 |
D/D |
2,353 |
2,353 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-06-01 |
4 |
AS |
$287.97 |
$140,241 |
D/D |
(487) |
55,778 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-21 |
4 |
AS |
$25.04 |
$145,232 |
D/D |
(5,800) |
857,231 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-02-13 |
4 |
AS |
$316.81 |
$153,970 |
D/D |
(486) |
57,331 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-06-02 |
4 |
AS |
$318.93 |
$154,362 |
D/D |
(484) |
23,535 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-02 |
4 |
AS |
$143.50 |
$169,761 |
D/D |
(1,183) |
63,917 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-30 |
4 |
AS |
$20.00 |
$170,000 |
D/D |
(8,500) |
1,496,981 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
Director |
– • – |
2024-02-20 |
4 |
AS |
$10.22 |
$172,385 |
D/D |
(16,872) |
140,739 |
0 |
- |
|
376 Records found
|
|
Page 11 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
